|
|
||||||||
Institute of Biochemistry, Faculty of Medicine, University Erlangen-Nuremberg, 91054 Erlangen, Germany
1Correspondence: Institute of Biochemistry, Faculty of Medicine, University Erlangen-Nuremberg, Fahrstr. 17, 91054 Erlangen, Germany. E-mail: thymosin{at}biochem.uni-erlangen.de
The ß-thymosins constitute a family of highly conserved and extremely water-soluble 5 kDa polypeptides. Thymosin ß4 is the most abundant member; it is expressed in most cell types and is regarded as the main intracellular G-actin sequestering peptide. There is increasing evidence for extracellular functions of thymosin ß4. For example, thymosin ß4 increases the rate of attachment and spreading of endothelial cells on matrix components and stimulates the migration of human umbilical vein endothelial cells. Here we show that thymosin ß4 can be cross-linked to proteins such as fibrin and collagen by tissue transglutaminase. Thymosin ß4 is not cross-linked to many other proteins and its cross-linking to fibrin is competed by another family member, thymosin ß10. After activation of human platelets with thrombin, thymosin ß4 is released and cross-linked to fibrin in a time- and calcium-dependent manner. We suggest that thymosin ß4 cross-linking is mediated by factor XIIIa, a transglutaminase that is coreleased from stimulated platelets. This provides a mechanism to increase the local concentration of thymosin ß4 near sites of clots and tissue damage, where it may contribute to wound healing, angiogenesis and inflammatory responses.Huff, T., Otto, A. M., Müller, C. S. G., Meier, M., Hannappel, E. Thymosin ß4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen.
Key Words: ß-thymosins cross-linking actin
This article has been cited by other articles:
![]() |
B. J. Xu, Y. Shyr, X. Liang, L.-j. Ma, E. M. Donnert, J. D. Roberts, X. Zhang, V. Kon, N. J. Brown, R. M. Caprioli, et al. Proteomic Patterns and Prediction of Glomerulosclerosis and Its Mechanisms J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2967 - 2975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Clark and J. G.F. Cleland Anemia and Chronic Heart Failure: Are We Asking the Right Questions? Circulation, September 20, 2005; 112(12): 1681 - 1683. [Full Text] [PDF] |
||||
![]() |
T. Huff, O. Rosorius, A. M. Otto, C. S. G. Muller, E. Ballweber, E. Hannappel, and H. G. Mannherz Nuclear localisation of the G-actin sequestering peptide thymosin {beta}4 J. Cell Sci., October 15, 2004; 117(22): 5333 - 5341. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. I. Al-Nedawi, M. Czyz, R. Bednarek, J. Szemraj, M. Swiatkowska, A. Cierniewska-Cieslak, J. Wyczolkowska, and C. S. Cierniewski Thymosin {beta}4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression Blood, February 15, 2004; 103(4): 1319 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Goldstein Thymosin {beta}4: A New Molecular Target for Antitumor Strategies J Natl Cancer Inst, November 19, 2003; 95(22): 1646 - 1647. [Full Text] [PDF] |
||||
![]() |
A. S. Weyrich and G. A. Zimmerman Evaluating the relevance of the platelet transcriptome Blood, August 15, 2003; 102(4): 1550 - 1551. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |